ArticleProceedings of the National Academy of Sciences of the United States of America2020

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.

Joseph A Flores-Toro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.